[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-366557-105":59,"doc-detail-366557-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","systematic-profiling-of-cancer-fibroblast-interactions-reveals-drug-combinations-in-ovarian-cancer","Systematic proﬁling of cancer-ﬁbroblast interactions reveals drug combinations in ovarian cancer","","Ovarian cancer is a leading cause of death among gynecological malignancies, and limited treatment responsiveness drives the need to clarify how the tumor microenvironment shapes disease progression. This study characterizes the impact of cancer-associated fibroblasts on ovarian cancer cell behavior and drug response. Direct and indirect co-culture models show fibroblast-dependent changes in proliferation, morphology, and secretome. An imaging-based high-throughput screen of 528 oncology compounds identifies drugs and combinations, including Birinapant and Vorinostat with Carboplatin, with altered efficacy in co-culture conditions.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/systematic-profiling-of-cancer-fibroblast-interactions-reveals-drug-combinations-in-ovarian-cancer/366557/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/systematic-profiling-of-cancer-fibroblast-interactions-reveals-drug-combinations-in-ovarian-cancer/366557.png","ImageObject",300,407,{"name":92,"@type":93},"Jasmine","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-10-23","2026-09-23",true,{"@type":102,"interactionType":103,"userInteractionCount":19},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"What role do cancer-associated fibroblasts play in ovarian cancer progression in this study?","Question",{"text":112,"@type":113},"The study investigates fibroblasts as non-cancerous components that create complex cellular and molecular interactions influencing ovarian cancer progression and treatment response.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"How did the researchers evaluate the effect of fibroblasts on drug response?",{"text":117,"@type":113},"They used direct and indirect co-culture systems and performed an imaging-based high-throughput screen of 528 oncology compounds to test drug efficacy under co-culture conditions.",{"name":119,"@type":110,"acceptedAnswer":120},"Which drug combinations were highlighted as promising treatments?",{"text":121,"@type":113},"The findings emphasize combinations involving Birinapant and Vorinostat with Carboplatin, supported by increased sensitivity in ex vivo cultures.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},366557,1790727559,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":19,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":46,"language":139,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":140,"faqs":141,"seo_title":142,"seo_description":67,"update_tm":143,"read_time":31,"preview_page_count":19,"preview_urls":144},2336478487870,"https://ap-avatar.wpscdn.com/davatar_085a072bc5b1113ac321206ff7593b45","Systematic proﬁling of cancer-ﬁbroblast interactions reveals drug combinations in ovarian cancer  \nGreta Gudoityte 1 , Osheen Sharma 1, Laura Leuenberger 1, Emelie Wallin2,3, Joseﬁn Fernebro2,3, P€aivi €Ostling 1, Rebecka Bergstr€om4 , Johan Lindberg4, Ulrika Joneborg2,5, Olli Kallioniemi 1,6 and Brinton Seashore-Ludlow 1  \n1 Science for Life Laboratory, Department of Oncology-Pathology, Karolinska Institutet, Stockholm, Sweden  \n2 Department of Oncology and Pathology, Karolinska Institutet, Stockholm, Sweden  \n3 Department of Pelvic Cancer, Karolinska University Hospital, Stockholm, Sweden  \n4 Department of Molecular Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden  \n5 Department of Women’s and Children’s Health, Karolinska Institutet, Stockholm, Sweden  \n6 Institute for Molecular Medicine Finland, University of Helsinki, Finland  \nKeywords  \ncancer-associated ﬁbroblast; drug screen; ovarian cancer; tumor microenvironment  \nCorrespondence  \nG. Gudoityte, Science for Life Laboratory, Department of Oncology-Pathology, Karolinska Institutet, Stockholm, Sweden E-mail: [greta.gudoityte@ki.se](greta.gudoityte@ki.se)  \nand  \nB. Seashore-Ludlow, Science for Life Laboratory, Department of OncologyPathology, Karolinska Institutet, Stockholm, Sweden  \nE-mail: brinton.seashore-ludlow@ki.se  \nOvarian cancer (OC) is a leading cause of death of gynecological cancersin women. Poor patient response to treatment highlights the need to better understand how the tumor microenvironment affects OC progression. Growing evidence indicates the crucial role of non-cancerous components, such as cancer-associated ﬁbroblasts, in establishing a complex network of cellular and molecular interactions, inﬂuencing cancer progression and response to treatment. Therefore, in this study, we sought to characterize the impact of ﬁbroblasts on OC cell behavior and drug response. Using both direct and indirect cell co-culture systems, we observed distinct changes in cancer cell proliferation, morphology, and secretome in the presence of ﬁbroblasts. Furthermore, an imaging-based high-throughput drug screen of 528 oncology compounds revealed multiple drugs that showed altered efﬁcacy in the co-culture conditions, demonstrating the role of ﬁbroblasts in driving cancer cell resistance to treatment. Most importantly, our data identiﬁed the two drug combinations of Birinapant or  \nAbbreviations  \nANAX1, annexin A1; AREG, amphiregulin; BRCA1/2, breast cancer type ½ susceptibility protein; BSA, bovine serum albumin; CA-125, cancer antigen 125 (mucin-16); CAFs, cancer-associated ﬁbroblasts; CD31, platelet and endothelial cell adhesion molecule; CD90, thy-1 cell surface antigen; CK8/18, keratin 8/18; CM, conditioned media; CNAs, copy number alterations; CP, CellProﬁler analyst; CPE, carboxypeptidase E; CTSV, cathepsin V; D-CC, direct co-culture; DMSO, dimethyl sulfoxide; ECM, extracellular matrix components; EDTA, ethylenediaminetetraacetic acid; EMT, epithelial-mesenchymal transition; EpCam, epithelial cell adhesion molecule; ERBB4, erb-b4 receptor tyrosine kinase; FBS, fetal bovine serum; FC, fold change; FIMM, Institute Molecular Medicine Finland; FOV, ﬁeld of view; FSP-1, ﬁbroblastspeciﬁc protein-1; Gal-1, galectin-1; GPNMB, transmembrane glycoprotein NMB; HDAC, histone deacetylase; HGF, hepatocyte growth factor; HGSOC, high grade serous ovarian cancer; hK8, kallrikrein-8; HRD, homologous recombination deﬁciency; I-CC, indirect co-culture; IC, IncuCyte􀀁 software; IF, immunoﬂuorescence; ITGB5, integrin beta-5; JAK1, Janus kinase 1; KUH, Karolinska University Hospital; MEK, mitogen-activated protein kinase kinase; MoA, mechanism of action; mTORC1/2, mammalian target of rapamycin complex 1/2; NF,  \nnon-cancerous ﬁbroblasts; NGI, national genomics infrastructure; NPX, Normalized Protein Expression; PARP, poly (ADP-ribose) polymerase; PBS, phosphate-buffered saline; PDFs, Patient-derived ﬁbroblasts; PDPN, podoplanin; PEGPH20, Pegylated recombinant human","cbCaitJ9HyO3WTv6","https://ap.wps.com/l/cbCaitJ9HyO3WTv6","pdf",2084896,"English","# Introduction\n## Background on ovarian cancer and the tumor microenvironment\n# Experimental approach\n## Direct and indirect co-culture systems\n## Imaging-based high-throughput drug screening\n# Key findings\n## Fibroblast-driven changes in cancer cells\n## Identified drug combinations and altered drug efficacy\n# Implications","[{\"question\":\"What role do cancer-associated fibroblasts play in ovarian cancer progression in this study?\",\"answer\":\"The study investigates fibroblasts as non-cancerous components that create complex cellular and molecular interactions influencing ovarian cancer progression and treatment response.\"},{\"question\":\"How did the researchers evaluate the effect of fibroblasts on drug response?\",\"answer\":\"They used direct and indirect co-culture systems and performed an imaging-based high-throughput screen of 528 oncology compounds to test drug efficacy under co-culture conditions.\"},{\"question\":\"Which drug combinations were highlighted as promising treatments?\",\"answer\":\"The findings emphasize combinations involving Birinapant and Vorinostat with Carboplatin, supported by increased sensitivity in ex vivo cultures.\"}]","Systematic proﬁling of cancer-ﬁbroblast interactions reveals drug combinations in ovarian cancer | PDF",1790166076,[145,149,153,157],{"page_no":8,"url":146,"width":147,"height":148},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/5f573ad77866f737197212787842329a.webp",983,1291,{"page_no":14,"url":150,"width":151,"height":152},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/465c8df45a5f18d9ed86d9c2b4e5fdb8.webp",982,1290,{"page_no":81,"url":154,"width":155,"height":156},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/9be83e68df9c9b86a55631d2f02ecc00.webp",981,1289,{"page_no":19,"url":158,"width":159,"height":160},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/635f30dfc3e284dde60ab3b7b7faf816.webp",980,1287]